Scholarly Index
Linong Ji
Peking University; 12,166 total citations; 368 total publications; best world rank #55
Peking University
12,166Total citations
368Total publications
47H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Diabetes Management and Research | Lifetime | 538 | CN 5 | 98.20 |
| Diabetes Treatment and Management | Lifetime | 551 | CN 8 | 98.03 |
| Diabetes Management and Education | Lifetime | 506 | CN 10 | 95.57 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | Lifetime | 632 | CN 4 | 93.48 |
| Pharmacology and Obesity Treatment | Lifetime | 804 | CN 9 | 92.26 |
| Diabetes Management and Research | 2021-2025 | 135 | CN 5 | 98.03 |
| Diabetes Treatment and Management | 2021-2025 | 183 | CN 6 | 97.92 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 90 | CN 7 | 96.90 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | 2021-2025 | 55 | CN 2 | 93.35 |
| Pancreatic function and diabetes | 2021-2025 | 413 | CN 13 | 93.14 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 314 | CN 62 | 93.09 |
| Diabetes Management and Education | 2021-2025 | 845 | CN 40 | 74.63 |
| Growth Hormone and Insulin-like Growth Factors | 2021-2025 | 769 | CN 77 | 74.13 |
| Pharmacology and Obesity Treatment | 2021-2025 | 498 | CN 23 | 72.26 |
| Peroxisome Proliferator-Activated Receptors | 2021-2025 | 904 | CN 313 | 58.84 |